Abstract
Cognitive decline in aging has a multifactorial etiology with both environmental and genetic components. A prominent genetic factor of relevance to cognitive decline is the ε4 variant of the apolipoprotein E (APOE) gene, a strong predictor of increased risk and earlier onset of Alzheimer disease.1,2 Apolipoprotein E (apoE) is critical for basic neurological processes relevant to nondemented neurological health, including neuronal proliferation, repair, and remyelination.3 However, the impact of APOE genotype on nondemented cognitive function remains unclear, with worse cognitive performance for ε4 allele carriers not consistently reported.4 A meta-analysis found that in adults without dementia, the APOE ε4 genotype was associated with small decrements in global cognition, episodic memory, and executive functioning.5 The mixed findings and modest effects suggest that APOE may be important to nondemented cognitive function, but more complicated causal pathways may be involved, including interactions with other neurological insults that may modify the effects of APOE.

This publication has 53 references indexed in Scilit: